oxytetracycline--anhydrous and Intracranial-Hypertension

oxytetracycline--anhydrous has been researched along with Intracranial-Hypertension* in 1 studies

Other Studies

1 other study(ies) available for oxytetracycline--anhydrous and Intracranial-Hypertension

ArticleYear
Fulminant intracranial hypertension secondary to oxytetracycline requiring urgent ventriculo-peritoneal shunt insertion.
    Neuro-Chirurgie, 2021, Volume: 67, Issue:6

    Idiopathic intracranial hypertension is a syndrome that presents with headaches and visual loss. Its pathogenesis is unknown. Treatment options include acetazolamide, therapeutic lumbar punctures or permanent CSF diversion. We present the only reported case of acute drug-induced intracranial hypertension secondary to oxytetracycline requiring urgent cerebrospinal fluid diversion. The patient's rapid visual failure progressed daily despite discontinuation of the drug and required an urgent ventriculo-peritoneal (VP) shunt insertion. Patients should be counselled about the rare potential risk of developing intracranial hypertension when commencing oxytetracycline. Rapid visual failure in IIH is a neurosurgical emergency necessitating urgent ventriculoperitoneal shunt insertion.

    Topics: Humans; Intracranial Hypertension; Oxytetracycline; Pseudotumor Cerebri; Treatment Outcome; Ventriculoperitoneal Shunt; Vision Disorders

2021